Mapping Epitopes Recognised by Autoantibodies Shows Potential for the Diagnosis of High-Grade Serous Ovarian Cancer and Monitoring Response to Therapy for This Malignancy

SIMPLE SUMMARY: Most women are diagnosed with high-grade serous ovarian cancer (HGSOC) at stage III, when the cancer has already spread, contributing to poor survival outcomes. However, while earlier diagnosis increases survival rates, there is a lack of early diagnosis biomarkers. Previously, autoa...

Descripción completa

Detalles Bibliográficos
Autores principales: Moody, Rhiane, Wilson, Kirsty, Kampan, Nirmala Chandralega, McNally, Orla M., Jobling, Thomas W., Jaworowski, Anthony, Stephens, Andrew N., Plebanski, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392293/
https://www.ncbi.nlm.nih.gov/pubmed/34439354
http://dx.doi.org/10.3390/cancers13164201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392293/
https://www.ncbi.nlm.nih.gov/pubmed/34439354
http://dx.doi.org/10.3390/cancers13164201

Ejemplares similares